Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00371111
Status:
UNKNOWN
Last Update Posted:
2008-07-30
First Post:
2006-08-31
Brief Title:
To Compare Therapeutic Effect of Intravitreal Bevacizumab and Triamcinolone in Resistant Uveitic Cystoid Macular Edema
Sponsor:
Shahid Beheshti University of Medical Sciences
Organization:
Shahid Beheshti University of Medical Sciences
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2008-07
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Cystoid macular edema CME is one of the common causes of vision loss in patients with UveitiS Triamcinolone has been effectively used in reducing CME and improving the vision Also there are some documents which recommend Bevacizumabavastin could reduce macular edema This study compare intravitreous injection of triamcinolone and avastin in patients with resistant uveitic cystoid macular edema
Detailed Description:
This study compare intravitreous injection of triamcinolone and avastin in patients with resistant uveitic cystoid macular edema
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None